Land: Australië
Taal: Engels
Bron: Department of Health (Therapeutic Goods Administration)
risperidone, Quantity: 4 mg
Medis Pharma Pty Ltd
Risperidone
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; maize starch; indigo carmine; hypromellose; magnesium stearate; quinoline yellow; microcrystalline cellulose; lactose monohydrate; titanium dioxide; macrogol 400
Oral
60 tablets
(S4) Prescription Only Medicine
Risperidone Ascent is indicated for the treatment of schizophrenia and related psychoses. Risperidone Ascent is indicated for the treatment of behavioural disturbances in dementia. Risperidone Ascent is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. (See Clinical Trials for maintenance data).
Visual Identification: Green, film-coated, oblong tablet engraved with "R", a breakline and "4" on one side and a plain face on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-09-26